Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. NEW BRUNSWICK, N.J., Sept. 21, 2021 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced new data reinforcing the… NEW BRUNSWICK, N.J., Sept. 21, 2021 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine.

Read the source article at luxembourgnewstoday.com
2021-09-21 13:28:50